Search research articles
Contact Us
Filters
Showing results (61-70 of 65) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 65 results.
Oncology Reports
|
March 9, 2018
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
Silvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
Oncology Reports
|
March 9, 2018
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo
Silvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
Endocrine
|
April 2, 2026
The pyrazolo[3,4-d]pyrimidine derivative CLM24 has an antineoplastic effect in aggressive dedifferentiated thyroid cancer in vitro
Silvia Martina Ferrari, Francesca Ragusa, Giusy Elia, et al.
Current Pharmaceutical Design
|
September 3, 2021
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments
Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
Current Pharmaceutical Design
|
June 21, 2022
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies
Clodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 65) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 65 results.
Oncology Reports
|
March 9, 2018
Lenvatinib exhibits antineoplastic activity in anaplastic thyroid cancer in vitro and in vivo
Silvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
Oncology Reports
|
March 9, 2018
Vandetanib has antineoplastic activity in anaplastic thyroid cancer, in vitro and in vivo
Silvia Martina Ferrari, Guido Bocci, Teresa Di Desidero, et al.
Endocrine
|
April 2, 2026
The pyrazolo[3,4-d]pyrimidine derivative CLM24 has an antineoplastic effect in aggressive dedifferentiated thyroid cancer in vitro
Silvia Martina Ferrari, Francesca Ragusa, Giusy Elia, et al.
Current Pharmaceutical Design
|
September 3, 2021
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments
Clodoveo Ferri, Dilia Giuggioli, Vincenzo Raimondo, et al.
Current Pharmaceutical Design
|
June 21, 2022
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies
Clodoveo Ferri, Vincenzo Raimondo, Laura Gragnani, et al.
Page
of 7